speb/financial-data huggingface dataset:
4524.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 56376507.741277896
P/B ratio: 0.6941287926473008
Pays dividend: no
Net asset value (USD): 79447934.76807913
Net cash (USD): -25424408.501537226
Net cash to market cap %: -45.097522922516745
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4524.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 58365991.47695819
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4524.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 59552047.01043069
P/B ratio: 0.710569631102457
Pays dividend: no
Net asset value (USD): 81951547.77927323
Net cash (USD): -30753701.211305518
Net cash to market cap %: -51.64171973117722
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4524.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 56131811.81181181
P/E ratio: 0.09071469644946348
P/B ratio: 0.7028100435419237
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 79335585.58558558
Net cash (USD): -23892642.64264264
Net cash to market cap %: -42.56524397029157
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4536.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2931831324.203245
Net income (USD): 223061793.14866415
P/E ratio: 13.143583590979498
P/B ratio: 1.0620407612404552
Pays dividend: no
Net asset value (USD): 1698664153.4174726
Net cash (USD): -318185543.35354865
Net cash to market cap %: -10.8527915888892
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.812178218181622 (Safe Zone)
Piotroski F-score: 3 (Weak)
4536.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Speculative (confidence: Low)
Market cap (USD): 2550748767.397748
Net income (USD): -112222222.22222224
EPS growth %: -150.30992562111675
Revenue growth %: -3.996391878194038
Smoothed growth %: -150.30992562111675
P/B ratio: 1.1584153121831455
Pays dividend: no
Net asset value (USD): 1484009009.0090091
Net cash (USD): -519557057.0570571
Net cash to market cap %: -20.368805571828414
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.3765321369690264 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4536.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 3087000430.412441
Net income (USD): 176327258.32012677
Revenue growth %: -4.817208462609987
EPS 2-year CAGR %: -11.09071189776374
Smoothed growth %: -4.817208462609987
P/E ratio: 17.507221854535448
P/B ratio: 1.5309194619678488
Pays dividend: no
Net asset value (USD): 1467485472.794506
Net cash (USD): -233551241.41574228
Net cash to market cap %: -7.565636827091033
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.303231973658674 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4536.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 2981273230.7005744
Net income (USD): 242320545.38163346
EPS growth %: 37.42659398792111
Revenue growth %: 0.5591023496007496
Smoothed growth %: 37.42659398792111
P/E ratio: 12.30301469487588
P/B ratio: 1.5641227879045938
PEG ratio: 0.3287238667469046
Pays dividend: no
Net asset value (USD): 1408735463.1733725
Net cash (USD): -201189680.5239941
Net cash to market cap %: -6.748448228501223
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.451627793995389 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4536.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Stalwart (confidence: High)
Market cap (USD): 3971783777.3773775
Net income (USD): 234991241.24124125
EPS growth %: -3.024631745050428
Revenue growth %: -9.00858959518177
EPS 2-year CAGR %: 15.442602881267753
Smoothed growth %: 15.442602881267753
P/E ratio: 0.09809910903262971
P/B ratio: 1.9403370325200917
PEG ratio: 0.006352498331199482
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 1409728478.4784784
Net cash (USD): -273185685.6856857
Net cash to market cap %: -6.878161073160783
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.199744753572809 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4538.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 127045884.12459727
P/B ratio: 0.47861771333271763
Pays dividend: no
Net asset value (USD): 258971844.79618993
Net cash (USD): -234500630.34038383
Net cash to market cap %: -184.57947847440917
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4538.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 133941891.06041974
P/B ratio: 0.6064941361395757
Pays dividend: no
Net asset value (USD): 210727175.5112953
Net cash (USD): -283531613.4206656
Net cash to market cap %: -211.68255216940875
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4538.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 120384115.30881539
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4538.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 120547641.21002692
P/B ratio: 0.5267401636029758
Pays dividend: no
Net asset value (USD): 219104979.8115747
Net cash (USD): -314851951.54777926
Net cash to market cap %: -261.1846639116075
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4538.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 117662186.98698698
P/E ratio: 0.0627165006513386
P/B ratio: 0.5754357621302449
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 210867117.1171171
Net cash (USD): -315440440.4404404
Net cash to market cap %: -268.0899008577216
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4558.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 21455941.480740864
Net income (USD): 272234.0599901656
P/E ratio: 78.81431692094647
P/B ratio: 0.999797592698955
Pays dividend: no
Net asset value (USD): 20794443.53384691
Net cash (USD): -10469226.356335025
Net cash to market cap %: -48.79406650942044
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.1182488641806323 (Grey Zone)
Piotroski F-score: 1 (Weak)
4558.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 16725715.428903906
Net income (USD): 108761.26126126127
EPS growth %: -60.0486209311244
Revenue growth %: -2.640170365436425
Smoothed growth %: -60.0486209311244
P/E ratio: 153.78375751570374
P/B ratio: 0.8623695365141522
Pays dividend: no
Net asset value (USD): 17796021.021021023
Net cash (USD): -11684662.162162164
Net cash to market cap %: -69.8604625424259
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0620451825258757 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4558.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Speculative (confidence: Low)
Market cap (USD): 14181099.498745376
Net income (USD): -180388.27258320127
EPS growth %: -265.8570988340057
Revenue growth %: -5.370039286621039
Smoothed growth %: -5.370039286621039
P/B ratio: 0.8512598968500479
Pays dividend: no
Net asset value (USD): 15544756.999471739
Net cash (USD): -9591382.725832013
Net cash to market cap %: -67.63497235655514
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.174520066899583 (Grey Zone)
Piotroski F-score: 5 (Neutral)
4558.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14350032.978478814
Net income (USD): 301751.1027937441
Revenue growth %: 4.224570638911531
EPS 2-year CAGR %: 66.56636774705935
Smoothed growth %: 66.56636774705935
P/E ratio: 47.55585926818464
P/B ratio: 0.8499453048446897
PEG ratio: 0.7144127113693308
Pays dividend: no
Net asset value (USD): 16133404.625050126
Net cash (USD): -8713293.677315867
Net cash to market cap %: -60.719677023623994
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.3190532579481387 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4558.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Department Stores
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 13290915.715715716
Net income (USD): 523098.09809809807
EPS growth %: 73.35416283653194
Revenue growth %: -2.495359960653324
Smoothed growth %: 73.35416283653194
P/E ratio: 0.16119435762292905
P/B ratio: 0.8364667270742682
PEG ratio: 0.0021974807071569605
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 15829441.941941941
Net cash (USD): -8710010.010010011
Net cash to market cap %: -65.53355838161657
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.299698033037402 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4559.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 678044131.0647149
P/B ratio: 1.0930732740831601
Pays dividend: no
Net asset value (USD): 308029289.8165009
Net cash (USD): -318048536.2095532
Net cash to market cap %: -46.906760436098736
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4559.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 649989935.9673841
P/B ratio: 1.0830146327610601
Pays dividend: no
Net asset value (USD): 328687033.8190082
Net cash (USD): -305987789.06563294
Net cash to market cap %: -47.07577335181804
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
4559.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 621647004.1080818
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4559.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 594546835.7559892
P/B ratio: 0.9623127446918578
Pays dividend: no
Net asset value (USD): 354330531.628533
Net cash (USD): -297943257.06594884
Net cash to market cap %: -50.11266382186738
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4559.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 573881580.7807808
P/E ratio: 0.07157180634013906
P/B ratio: 0.8908840817242039
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 430523973.973974
Net cash (USD): -271103178.1781782
Net cash to market cap %: -47.24026476147488
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
455A.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
455A.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Technology | Industry: Software - Application
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
455A.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Slow Grower (confidence: High)
Market cap (USD): 3816891.503100825
Net income (USD): 371229.46103190334
P/E ratio: 0.08217750670157567
P/B ratio: 2.2734048850472943
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 1682002.4295121795
Net cash (USD): 451262.7069880441
Net cash to market cap %: 11.822780569514233
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.082037994781536 (Safe Zone)
Piotroski F-score: 4 (Weak)
4564.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 106096482.2524163
P/B ratio: 15.143155631528966
Pays dividend: no
Net asset value (USD): 7006233.36601765
Net cash (USD): 3855806.135313069
Net cash to market cap %: 3.634245031932013
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4564.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 74602459.67116696
P/B ratio: 15.309060906966282
Pays dividend: no
Net asset value (USD): 4873091.832642695
Net cash (USD): 2725517.978879829
Net cash to market cap %: 3.6533888974886066
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4564.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 85510315.05673955
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4564.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 69749211.79004039
P/B ratio: 6.296535189517534
Pays dividend: no
Net asset value (USD): 11077395.693135936
Net cash (USD): 9327335.127860028
Net cash to market cap %: 13.372674598728432
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4564.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 52374345.54554554
P/B ratio: 3.908304981229992
Pays dividend: no
Net asset value (USD): 13400782.032032032
Net cash (USD): 11711492.742742743
Net cash to market cap %: 22.361124746767956
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4570.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 27798826.137134057
P/B ratio: 2.969066507578041
Pays dividend: no
Net asset value (USD): 9348522.201989073
Net cash (USD): 2955988.2336461693
Net cash to market cap %: 10.63350020272086
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4570.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 29751151.257184867
P/B ratio: 2.939439889154421
Pays dividend: no
Net asset value (USD): 10109397.139419863
Net cash (USD): 3306376.1529207327
Net cash to market cap %: 11.113439356812274
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4570.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 32020328.511347905
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4570.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 29643245.156527594
P/B ratio: 2.6600431467352017
Pays dividend: no
Net asset value (USD): 11133526.244952895
Net cash (USD): 4344367.429340512
Net cash to market cap %: 14.655505517026226
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4570.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: High)
Market cap (USD): 56344555.75575575
P/E ratio: 0.23784407637098856
P/B ratio: 6.780317307285445
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 11524543.293293294
Net cash (USD): 4240021.271271272
Net cash to market cap %: 7.525165855688093
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4574.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 93318355.21955621
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4574.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 106236127.62323552
P/B ratio: 1.9317117720319574
Pays dividend: no
Net asset value (USD): 54815942.43011347
Net cash (USD): 2816219.208414059
Net cash to market cap %: 2.6509053665827587
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4574.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 95986499.10903147
P/B ratio: 1.7625320880069986
Pays dividend: no
Net asset value (USD): 54242056.13451825
Net cash (USD): 3222300.364426825
Net cash to market cap %: 3.3570349938136617
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4574.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: High)
Market cap (USD): 81111152.75275275
P/E ratio: 0.10046791483917232
Dividend yield: 0.01
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4577.T — Peter Lynch category analysis (annual, as of 2022-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 237400845.09250274
Net income (USD): 36531538.58193771
P/E ratio: 6.498517563393315
P/B ratio: 0.6363424301130666
Pays dividend: no
Net asset value (USD): 367177962.12239784
Net cash (USD): -100853028.64298011
Net cash to market cap %: -42.482169178329144
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.1940432114111017 (Safe Zone)
Piotroski F-score: 2 (Weak)
4577.T — Peter Lynch category analysis (annual, as of 2023-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 195587119.86837402
Net income (USD): 25752915.08691609
EPS growth %: -29.504980938171858
Revenue growth %: -5.148706402139565
Smoothed growth %: -29.504980938171858
P/E ratio: 7.594756524
P/B ratio: 0.5364054753958133
Pays dividend: no
Net asset value (USD): 359789684.5267902
Net cash (USD): -114271407.11066599
Net cash to market cap %: -58.424812016030614
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.844500920784001 (Grey Zone)
Piotroski F-score: 4 (Weak)
4577.T — Peter Lynch category analysis (annual, as of 2024-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 190685361.36604017
Net income (USD): 20993947.116916217
EPS growth %: -18.479337014618945
Revenue growth %: -7.3905822603854645
EPS 2-year CAGR %: -24.192344112963728
Smoothed growth %: -18.479337014618945
P/E ratio: 9.082873282670715
P/B ratio: 0.5726325475738557
Pays dividend: no
Net asset value (USD): 328626951.25836253
Net cash (USD): -144740363.17298505
Net cash to market cap %: -75.9053354363899
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4972283322508444 (Grey Zone)
Piotroski F-score: 4 (Weak)
4577.T — Peter Lynch category analysis (annual, as of 2025-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 190713199.8423981
Net income (USD): 13270274.029767701
EPS growth %: -36.78999972770742
Revenue growth %: 17.884233816069127
EPS 2-year CAGR %: -28.216149939534397
Smoothed growth %: -36.78999972770742
P/E ratio: 14.371459053113206
P/B ratio: 0.5266434377502065
Pays dividend: no
Net asset value (USD): 357991375.7128947
Net cash (USD): -165043816.94255114
Net cash to market cap %: -86.54032184397322
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4410307598383545 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4577.T — Peter Lynch category analysis (annual, as of 2026-05-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: High)
Market cap (USD): 229921696.1386325
P/E ratio: 0.07018444044704546
Dividend yield: 0.04
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4594.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 49610955.098753326
P/B ratio: 5.739743724607124
Pays dividend: no
Net asset value (USD): 8643409.441098193
Net cash (USD): 7545006.303403838
Net cash to market cap %: 15.208347205541777
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4594.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 40844897.98155327
P/B ratio: 6.606817439399083
Pays dividend: no
Net asset value (USD): 6182234.995321481
Net cash (USD): 4109370.4050260657
Net cash to market cap %: 10.06091484640744
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4594.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 65426550
P/B ratio: 6.369253571671899
Pays dividend: no
Net asset value (USD): 10272247.644683715
Net cash (USD): 7275605.6527590845
Net cash to market cap %: 11.120264866111821
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4594.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 40840136.13613614
P/B ratio: 4.046311308398904
Pays dividend: no
Net asset value (USD): 14817642.642642641
Net cash (USD): 12010673.173173174
Net cash to market cap %: 29.408993968915542
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4598.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 58381663.90250735
P/B ratio: 26.4198724984945
Pays dividend: no
Net asset value (USD): 2209763.27216697
Net cash (USD): 1672587.1970864267
Net cash to market cap %: 2.8649186838516827
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4598.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 54666897.13941986
P/B ratio: 29.443302663455697
Pays dividend: no
Net asset value (USD): 1856683.598449405
Net cash (USD): 1218366.5285389652
Net cash to market cap %: 2.228709863359724
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4598.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 69391678.7295876
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4598.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 51308841.668909825
P/B ratio: 21.449894985595964
Pays dividend: no
Net asset value (USD): 2392032.3014804847
Net cash (USD): 1899078.0619111708
Net cash to market cap %: 3.7012686315658962
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4598.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 9255376.976976978
P/B ratio: 81.62903946322939
Pays dividend: no
Net asset value (USD): 212593.84384384385
Net cash (USD): -420645.64564564556
Net cash to market cap %: -4.544878579143929
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4631.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1791961845.0729847
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4631.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1799790106.08421
P/B ratio: 0.6265794616768405
Pays dividend: no
Net asset value (USD): 2314987544.976474
Net cash (USD): -5067236368.668696
Net cash to market cap %: -281.54596202850814
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4631.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2186312266.095379
P/B ratio: 0.6966798036442904
Pays dividend: no
Net asset value (USD): 2613260021.7377405
Net cash (USD): -4567086503.420498
Net cash to market cap %: -208.89451951788374
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
4631.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2649738480.880881
P/E ratio: 0.06600099543565337
Dividend yield: 0.03
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4642.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 46285147.38347107
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4642.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 33617073.73397533
Net income (USD): 3126745.410773398
P/E ratio: 10.751458567155991
P/B ratio: 0.7261250997516144
Pays dividend: no
Net asset value (USD): 45330507.071922965
Net cash (USD): 17286691.242852844
Net cash to market cap %: 51.42235573402074
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.919458686164724 (Safe Zone)
Piotroski F-score: 4 (Weak)
4642.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 44446798.02241391
Net income (USD): 3375189.139503641
EPS growth %: 7.945761361773002
Revenue growth %: -3.888831442257991
Smoothed growth %: 7.945761361773002
P/E ratio: 13.168683645666833
P/B ratio: 0.9681261166613018
PEG ratio: 1.6573218155054683
Pays dividend: no
Net asset value (USD): 45043342.99653538
Net cash (USD): 18299759.598387893
Net cash to market cap %: 41.17227879758532
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.846484985844075 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4642.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 41641155.4997783
Net income (USD): 4141550.4172240268
EPS growth %: 22.705728362028555
Revenue growth %: -3.268878131896163
EPS 2-year CAGR %: 15.089370801521351
Smoothed growth %: 15.089370801521351
P/E ratio: 10.054484747209544
P/B ratio: 0.926014275116108
PEG ratio: 0.6663289596008751
Pays dividend: no
Net asset value (USD): 44194439.13625071
Net cash (USD): 16543480.476463469
Net cash to market cap %: 39.72867774178732
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.379350768650383 (Safe Zone)
Piotroski F-score: 8 (Strong)
4642.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 59214183.584385626
Net income (USD): 3461057.477143405
EPS growth %: -16.430874226486864
Revenue growth %: 20.001445129976315
EPS 2-year CAGR %: 1.2640629572846063
Smoothed growth %: 1.2640629572846063
P/E ratio: 17.108696973521006
P/B ratio: 1.2236582254636905
PEG ratio: 13.534687394267934
Pays dividend: no
Net asset value (USD): 34833635.956780255
Net cash (USD): -2535093.6640879773
Net cash to market cap %: -4.281227082148717
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.35362897140814 (Safe Zone)
Piotroski F-score: 4 (Weak)
4678.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 12134099.53081664
P/B ratio: 0.4323692798664938
Pays dividend: no
Net asset value (USD): 27927812.018489983
Net cash (USD): -27946610.169491526
Net cash to market cap %: -230.31466075019645
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4678.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 12188371.868667291
P/B ratio: 0.4019539780241919
Pays dividend: no
Net asset value (USD): 30201236.46571314
Net cash (USD): -23994185.269349016
Net cash to market cap %: -196.86128326155676
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4678.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: Low)
Market cap (USD): 13609714.145723773
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4678.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 12272033.640578736
P/B ratio: 0.44761147343612356
Pays dividend: no
Net asset value (USD): 27300753.701211307
Net cash (USD): -26771056.52759085
Net cash to market cap %: -218.14686393190453
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4678.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 13516750.35035035
P/E ratio: 0.32155602807776723
P/B ratio: 0.46671843541513575
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 29668049.2992993
Net cash (USD): -21401413.913913913
Net cash to market cap %: -158.33253821514276
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4680.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category:  (confidence: Low)
Market cap (USD): 1963646716.0308166
P/B ratio: 3.7201055929050226
Pays dividend: no
Net asset value (USD): 521760750.80543494
Net cash (USD): -516227762.99201566
Net cash to market cap %: -26.289238220787688
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4680.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category:  (confidence: Low)
Market cap (USD): 1697129308.9899747
P/B ratio: 3.7966042763535777
Pays dividend: no
Net asset value (USD): 440823419.3289667
Net cash (USD): -948242213.6078064
Net cash to market cap %: -55.87330373618619
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4680.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category:  (confidence: Medium)
Market cap (USD): 2633674236.715749
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4680.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category:  (confidence: Medium)
Market cap (USD): 2281932929.0920596
P/B ratio: 4.596218784486763
Pays dividend: no
Net asset value (USD): 491063257.0659489
Net cash (USD): -926655450.8748317
Net cash to market cap %: -40.60835614671336
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
4680.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category:  (confidence: High)
Market cap (USD): 1934048172.9729729
P/E ratio: 0.08052643286561414
P/B ratio: 2.5906481437545077
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 509547047.047047
Net cash (USD): -1067223473.4734734
Net cash to market cap %: -55.18081133589155
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
4705.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 19138169.022552177
P/B ratio: 0.56908634821436
Pays dividend: no
Net asset value (USD): 32302024.093010224
Net cash (USD): 14295657.655133773
Net cash to market cap %: 74.69710210150171
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4705.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 18646535.262665417
P/B ratio: 0.5813531549602237
Pays dividend: no
Net asset value (USD): 31181453.0143029
Net cash (USD): 15496464.376420265
Net cash to market cap %: 83.10640104517269
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4705.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: Low)
Market cap (USD): 19044587.497647386
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4705.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 18958271.810497984
P/B ratio: 0.6116200883432196
Pays dividend: no
Net asset value (USD): 30210995.96231494
Net cash (USD): 14460585.464333784
Net cash to market cap %: 76.27586316346807
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4705.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 17488099.2992993
P/B ratio: 0.6125805565999559
Dividend yield: 0.05
Pays dividend: yes
Net asset value (USD): 29073955.205205206
Net cash (USD): 13358621.12112112
Net cash to market cap %: 76.38692400183457
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4714.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: Low)
Market cap (USD): 254753598.75921547
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4714.T — Peter Lynch category analysis (quarterly, as of 2025-08-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: Low)
Market cap (USD): 237382754.0581784
P/B ratio: 3.185502990671328
Pays dividend: no
Net asset value (USD): 69974378.36364876
Net cash (USD): -28832801.961986504
Net cash to market cap %: -12.146123283631669
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4714.T — Peter Lynch category analysis (quarterly, as of 2026-02-28)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: Low)
Market cap (USD): 220716843.57756957
P/B ratio: 2.8046245414175215
Pays dividend: no
Net asset value (USD): 74890080.84178108
Net cash (USD): -14885833.4402669
Net cash to market cap %: -6.744312395458557
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4714.T — Peter Lynch category analysis (quarterly, as of 2026-05-31)
Sector: Consumer Defensive | Industry: Education & Training Services
Lynch category:  (confidence: High)
Market cap (USD): 212783458.12770766
P/E ratio: 0.12663373261413327
Dividend yield: 0.05
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4760.T — Peter Lynch category analysis (quarterly, as of 2025-02-28)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 7856501.510565963
P/B ratio: 0.8811017654873574
Pays dividend: no
Net asset value (USD): 8833911.07259516
Net cash (USD): -12017465.502299845
Net cash to market cap %: -152.96204660735995
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4760.T — Peter Lynch category analysis (quarterly, as of 2025-08-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category:  (confidence: Low)
Market cap (USD): 11239798.896382589
P/B ratio: 1.0832461732600265
Pays dividend: no
Net asset value (USD): 10235567.817971252
Net cash (USD): -14314592.274678111
Net cash to market cap %: -127.35630242712894
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
4760.T — Peter Lynch category analysis (quarterly, as of 2025-11-30)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category:  (confidence: Low)
Market cap (USD): 8180340.414640389
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4760.T — Peter Lynch category analysis (quarterly, as of 2026-02-28)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 8217860.336199152
P/E ratio: 0.05842366965451885
P/B ratio: 0.8692641488270522
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 9200333.632747337
Net cash (USD): -14181553.958680868
Net cash to market cap %: -172.56990723256789
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4820.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: Low)
Market cap (USD): 394189385.58503693
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4820.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 372784170.99872106
Net income (USD): 14241649.11224797
P/E ratio: 26.175632334469096
P/B ratio: 2.540919543056767
Pays dividend: no
Net asset value (USD): 129070117.36382788
Net cash (USD): 15294914.234125793
Net cash to market cap %: 4.102887253272957
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.498022519017817 (Safe Zone)
Piotroski F-score: 4 (Weak)
4820.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 305657992.1696245
Net income (USD): 14028141.129887577
EPS growth %: -1.4991801909848606
Revenue growth %: 13.06943122237991
Smoothed growth %: -1.4991801909848606
P/E ratio: 21.78891624624496
P/B ratio: 2.102179042625462
Pays dividend: no
Net asset value (USD): 108421127.05932263
Net cash (USD): 4369652.8317895755
Net cash to market cap %: 1.429588933949629
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.037067585124355 (Safe Zone)
Piotroski F-score: 4 (Weak)
4820.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 322524194.89358336
Net income (USD): 15593349.894897763
EPS growth %: 11.157634860654765
Revenue growth %: 9.925280503811043
EPS 2-year CAGR %: 4.638034011566061
Smoothed growth %: 4.638034011566061
P/E ratio: 20.683444998506396
P/B ratio: 2.455770363582484
PEG ratio: 4.459528530176194
Pays dividend: no
Net asset value (USD): 108898655.96534811
Net cash (USD): 5306070.450347155
Net cash to market cap %: 1.645169737451136
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.049999350304038 (Safe Zone)
Piotroski F-score: 8 (Strong)
4820.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 348691772.38253963
Net income (USD): 15753468.448308932
EPS growth %: 1.0268387132360874
Revenue growth %: -4.393732488423466
EPS 2-year CAGR %: 5.9712434994142916
Smoothed growth %: 5.9712434994142916
P/E ratio: 22.134285762318594
P/B ratio: 2.6696793831491026
PEG ratio: 3.70681345761393
Pays dividend: no
Net asset value (USD): 104654433.85972764
Net cash (USD): 4922958.890096538
Net cash to market cap %: 1.4118368370033414
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 7.017772335850198 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4833.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 34068742.15576411
P/B ratio: 8.831014997530973
Pays dividend: no
Net asset value (USD): 3857851.2396694217
Net cash (USD): 2243738.6188541814
Net cash to market cap %: 6.58591564254321
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4833.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 38334174.47533752
P/B ratio: 18.571657217145777
Pays dividend: no
Net asset value (USD): 2064122.443523593
Net cash (USD): 414122.443523593
Net cash to market cap %: 1.0802957131371662
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4833.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 57269787.64184888
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4833.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 59605961.170928665
P/B ratio: 2.6377947841179212
Pays dividend: no
Net asset value (USD): 22596890.982503366
Net cash (USD): 14190289.367429342
Net cash to market cap %: 23.806829197396294
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)